Literature DB >> 21324217

Low seroprevalence of Q fever in The Netherlands prior to a series of large outbreaks.

B Schimmer1, D W Notermans, M G Harms, J H J Reimerink, J Bakker, P Schneeberger, L Mollema, P Teunis, W van Pelt, Y van Duynhoven.   

Abstract

The Netherlands has experienced large community outbreaks of Q fever since 2007. Sera and questionnaires containing epidemiological data from 5654 individuals were obtained in a nationwide seroprevalence survey used to evaluate the National Immunization Programme in 2006-2007. We tested these sera for IgG phase-2 antibodies against Coxiella burnetii with an ELISA to estimate the seroprevalence and to identify determinants for seropositivity before the Q fever outbreaks occurred. Overall seroprevalence was 1·5% [95% confidence interval (CI) 1·3-1·7]. Corrected for confirmation with immunofluorescence results in a subset, the estimated seroprevalence was 2·4%. Seropositivity ranged from 0·48% (95% CI 0·00-0·96) in the 0-4 years age group to 2·30% (95% CI 1·46-3·15) in the 60-79 years age group. Keeping ruminants, increasing age and being born in Turkey were independent risk factors for seropositivity. The low seroprevalence before the start of the outbreaks supports the hypothesis that The Netherlands has been confronted with a newly emerging Q fever problem since spring 2007.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324217     DOI: 10.1017/S0950268811000136

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  27 in total

1.  A Q Fever Outbreak in the Netherlands: Consequences for Tissue Banking.

Authors:  Marja J van Wijk; Boris M Hogema; D Willemijn Maas; Arlinke G Bokhorst
Journal:  Transfus Med Hemother       Date:  2011-11-14       Impact factor: 3.747

Review 2.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Seroprevalence and risk factors for Coxiella burnetii (Q fever) seropositivity in dairy goat farmers' households in The Netherlands, 2009-2010.

Authors:  Barbara Schimmer; Anke Lenferink; Peter Schneeberger; Helen Aangenend; Piet Vellema; Jeannine Hautvast; Yvonne van Duynhoven
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

4.  Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii.

Authors:  C C H Wielders; L M Kampschreur; P M Schneeberger; M M Jager; A I M Hoepelman; A C A P Leenders; M H A Hermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

5.  Coxiella burnetii Antibody Prevalence and Risk Factors of Infection in the Human Population of Estonia.

Authors:  Kädi Neare; Marilin Janson; Pirje Hütt; Brian Lassen; Arvo Viltrop
Journal:  Microorganisms       Date:  2019-11-29

6.  Proximity to goat farms and Coxiella burnetii seroprevalence among pregnant women.

Authors:  Wim van der Hoek; Jamie C E Meekelenkamp; Frederika Dijkstra; Daan W Notermans; Ben Bom; Piet Vellema; Ariene Rietveld; Yvonne T H P van Duynhoven; Alexander C A P Leenders
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

7.  Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak.

Authors:  L M Kampschreur; J C J P Hagenaars; C C H Wielders; P Elsman; P J Lestrade; O H J Koning; J J Oosterheert; N H M Renders; P C Wever
Journal:  Epidemiol Infect       Date:  2012-06-13       Impact factor: 4.434

8.  Waning population immunity prior to a large Q fever epidemic in the south of The Netherlands.

Authors:  D A H Brandwagt; T Herremans; P M Schneeberger; V H Hackert; C J P A Hoebe; J Paget; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2016-04-14       Impact factor: 4.434

9.  Antibodies against Coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in The Netherlands.

Authors:  Wim van der Hoek; Jamie C E Meekelenkamp; Alexander C A P Leenders; Nancy Wijers; Daan W Notermans; Chantal W P M Hukkelhoven
Journal:  BMC Infect Dis       Date:  2011-02-11       Impact factor: 3.090

10.  Risk factors of Coxiella burnetii (Q fever) seropositivity in veterinary medicine students.

Authors:  Myrna M T de Rooij; Barbara Schimmer; Bart Versteeg; Peter Schneeberger; Boyd R Berends; Dick Heederik; Wim van der Hoek; Inge M Wouters
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.